[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354770-105":59,"doc-detail-354770-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","knockdown-of-rpl28-inhibits-the-progression-of-clear-cell-renal-cell-carcinoma","Knockdown of RPL28 Inhibits the Progression of Clear Cell Renal Cell Carcinoma","","Clear cell renal cell carcinoma (ccRCC) is a common and aggressive kidney cancer, and the biological role of ribosomal protein L28 (RPL28) in this disease has remained unclear. This study assessed RPL28 expression, prognostic value, and potential mechanisms by integrating public expression datasets and pan-cancer analyses, validating in clinical ccRCC tissues, and combining survival, immune-infiltration, and drug-sensitivity profiling. Lentivirus-mediated knockdown showed that RPL28 suppresses ccRCC proliferation and migration, with results suggesting involvement in EMT-related processes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/knockdown-of-rpl28-inhibits-the-progression-of-clear-cell-renal-cell-carcinoma/354770/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/knockdown-of-rpl28-inhibits-the-progression-of-clear-cell-renal-cell-carcinoma/354770.png","ImageObject",300,407,{"name":92,"@type":93},"acoobca","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main objective of the study on RPL28 in ccRCC?","Question",{"text":112,"@type":113},"To determine the expression pattern of RPL28, its prognostic significance, and its potential biological role in clear cell renal cell carcinoma.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was RPL28 expression evaluated and validated?",{"text":117,"@type":113},"Expression data and clinicopathological information were obtained from the UCSC Xena platform, pan-cancer patterns were assessed using TIMER2.0, and RPL28 was validated in clinical ccRCC tissue samples.",{"name":119,"@type":110,"acceptedAnswer":120},"What effects did RPL28 knockdown have in ccRCC cells?",{"text":121,"@type":113},"Lentivirus-mediated knockdown significantly inhibited ccRCC cell proliferation and migration, and supported a role for RPL28 in EMT-related processes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},354770,1790865395,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},3985747870733,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Cancer Reports  \nORIGINAL ARTICLE  OPEN ACCESS   \nKnockdown of RPL28 Inhibits the Progression of Clear Cell Renal Cell Carcinoma  \nRunbiao Luo1  | Guozhong Wu1 | Zhouzhou Xie2  | Yuchen Xiao3 | Wenbiao Zhu4 | Huiming Jiang1   \n1Department of Urology, Meizhou People's Hospital, Meizhou Academy of Medical Sciences, Meizhou, People's Republic of China | 2Affiliated Meizhou Hospital of Shantou University Medical College, Meizhou, People's Republic of China | 3Shantou University Medical College, Shantou, People's Republic of China | 4Department of Pathology, Affiliated Meizhou Hospital of Shantou University Medical College, Meizhou, People's Republic of China  \nCorrespondence: Huiming Jiang ([jianghuiming@mzrmyy.com](jianghuiming@mzrmyy.com); [jianghm0228@163.com](jianghm0228@163.com)) | Wenbiao Zhu ([zhuwenbiao@mzrmyy.com](zhuwenbiao@mzrmyy.com))  \nReceived: 20 October 2025 | Revised: 6 August 2026 | Accepted: 31 August 2026  \nKeywords: biomarker | clear cell renal cell carcinoma | prognosis | RPL28  \nABSTRACT  \nBackground: Clear cell renal cell carcinoma (ccRCC) is the most common and aggressive histological subtype of kidney cancer. Previous studies have implicated ribosomal protein L28 (RPL28) in the progression of various cancers; however, its role in ccRCC remains unclear.  \nAims: This study aimed to investigate the expression, prognostic significance, and potential biological role of RPL28 inccRCC.  \nMethods and Results: RPL28 expression data and corresponding clinicopathological information were obtained from the UCSC Xena platform, and pan-cancer expression patterns were assessed using TIMER2.0 . RPL28 expression was further validated in clinical ccRCC tissue samples. Prognostic, immune-infiltration, and drug-sensitivity analyses were performed, and the biological effects of RPL28 were evaluated using lentivirus-mediated knockdown in ccRCC cells. RPL28 was significantly upregulated in ccRCC tissues and was associated with unfavorable overall survival (OS) and disease-specific survival (DSS), as well as adverse clinicopathological features, including higher histological grade, advanced T stage, distant metastasis, and advanced TNM stage. Immune analyses revealed associations between RPL28 expression and selected features of the ccRCC immune microenvironment, while pharmacogenomic analyses suggested potential associations between RPL28 expression and predicted sensitivity to selected targeted agents. In vitro, RPL28 knockdown significantly inhibited ccRCC cell proliferation and migration. Gene set enrichment analysis (GSEA), together with experimental findings, further suggested that RPL28 may be involved in epithelial–mesenchymal transition (EMT)-related processes in ccRCC.  \nConclusion: RPL28 is overexpressed in ccRCC and is associated with poor survival outcomes, malignant cellular phenotypes, EMT-related signaling, selected immune-microenvironmental features, and predicted therapeutic-response phenotypes. These findings suggest that RPL28 may serve as a prognostic biomarker and potential therapeutic target in ccRCC, although further mechanistic and clinical validation is required.  \n1 | Introduction  \nRenal cell carcinoma (RCC) constitutes a major malignancy within the urinary system, representing roughly 3.8% of cancer diagnoses in adults. Clear cell renal cell carcinoma (ccRCC)  \nstands as the predominant subtype, comprising approximately 75% of RCC cases [1]. Based on the 2023 Cancer Statistics Report, the United States is projected to see 81 800 new kidney cancer cases, with 14 890 related deaths [2] . Traditional treatments such as radiotherapy and chemotherapy demonstrate limited  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2026 The Author(s). Cancer Reports published by Wiley Periodicals LLC.  \nCancer Reports, 2026; 9:e70683 1 of 13  \n[https://doi.org/10","cbCaiiiSpckvfl9c","https://ap.wps.com/l/cbCaiiiSpckvfl9c","pdf",8222725,13,"English","# Introduction\n## Background on ccRCC and RPL28\n# Methods and Results\n## Expression analysis and validation\n## Prognosis, immune infiltration, and drug sensitivity\n## Functional assays and EMT signaling\n# Conclusion","[{\"question\":\"What was the main objective of the study on RPL28 in ccRCC?\",\"answer\":\"To determine the expression pattern of RPL28, its prognostic significance, and its potential biological role in clear cell renal cell carcinoma.\"},{\"question\":\"How was RPL28 expression evaluated and validated?\",\"answer\":\"Expression data and clinicopathological information were obtained from the UCSC Xena platform, pan-cancer patterns were assessed using TIMER2.0, and RPL28 was validated in clinical ccRCC tissue samples.\"},{\"question\":\"What effects did RPL28 knockdown have in ccRCC cells?\",\"answer\":\"Lentivirus-mediated knockdown significantly inhibited ccRCC cell proliferation and migration, and supported a role for RPL28 in EMT-related processes.\"}]","Knockdown of RPL28 Inhibits the Progression of Clear Cell Renal Cell Carcinoma | PDF",1790113686,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/68de6c27aab88c2c895e538b073b6c4e.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1d6855b8c24f21929b08dc5cdbf3df14.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d46c33a6bee647f92b4e8dc004d26169.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2e621efcc1dd572439dc628b13c5b1cb.webp",980,1287]